Comparison of Two Combination Chemotherapy Regimens in Treating Patients With Previously Untreated Aggressive Stage II, Stage III, or Stage IV Non-Hodgkin's Lymphoma

NCT00005964 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

59

Enrollment

OTHER

Sponsor class

Conditions

Lymphoma

Interventions

BIOLOGICAL: filgrastim
DRUG: cyclophosphamide
DRUG: doxorubicin hydrochloride
DRUG: etoposide
DRUG: prednisone
DRUG: vincristine sulfate

Sponsor

Alliance for Clinical Trials in Oncology

Collaborators

[object Object]